Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06011824 · ClinicalTrials.gov registry record
A Study of Effect of Megakaryocytes and Platelets in Breast Cancer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 23
- Enrollment target
NCT06011824: Completed study, sponsored by Mayo Clinic.
NCT06011824 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06011824 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 23 participants
- Enrollment target
Study Summary
Determining if Megakaryocytes and Platelets are Harmful or Helpful in Breast Cancer Cell Metastasis
Primary Outcome
Measure of the number of platelets in the blood, reported as platelets per microliter of blood.
Interventions
- OTHER Blood draw
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2025-04-29 |
What the finished NCT06011824 record still lists
NCT06011824 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 23 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Blood draw is the first listed.
NCT06011824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06011824 about?
NCT06011824 is a clinical study titled "A Study of Effect of Megakaryocytes and Platelets in Breast Cancer". Determining if Megakaryocytes and Platelets are Harmful or Helpful in Breast Cancer Cell Metastasis
What is the current status of trial NCT06011824?
This trial is currently completed. The enrollment target is 23 participants. The study started on 2023-08-29. Estimated completion is 2025-04-29.
What interventions are being tested in trial NCT06011824?
The interventions under investigation include: Blood draw (OTHER).
Who is sponsoring clinical trial NCT06011824?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI